How Is Unhealthy Lifestyle Fueling Human Insulin Demand?

The International Diabetes Federation (IDF) estimates that approximately 463 million adults within the age group of 20–79 years were living with diabetes in 2019, and the number is expected to rise to 700 million by 2045. This disease caused around 4.2 million deaths in 2019. As per the IDF, more than 1.1 million adolescents and children are currently living with type 1 diabetes. What is worse is that at present, around 374 million people are at an increased risk of developing type 2 diabetes.

Thus, the surging incidence of diabetes, owing to an unhealthy lifestyle, will aid the human insulin (HI) market in progressing at a CAGR of 8.8% during 2018–2023. According to P&S Intelligence, the market was valued at $42.9 billion in 2017, and it is expected to generate $70.6 billion revenue by 2023. Hectic work schedules often force people to eat unhealthy packaged food, which is high in sugar and carbohydrates. Additionally, the booming geriatric population will create a huge requirement for HI as it is highly susceptible to diabetes.

These products are manufactured by Gulf Pharmaceutical Industries (Julphar), Novo Nordisk A/S, Ypsomed AG, Wockhardt Ltd., Becton, Dickinson and Company, B. Braun Melsungen AG, Eli Lilly and Company, and Medtronic PLC. At present, these companies are focusing on product launches to offer new and improved HI variants and delivery devices to their existing and potential customers. For instance, Sanofi obtained the U.S. Food and Drug Administration (USFDA) approval for Admelog (insulin lispro injection) in December 2017. It is a rapid-acting insulin that enables people to manage their blood glucose levels at mealtime.

Globally, the North American region consumed the largest volume of HI and bought the highest number of delivery devices in the preceding years due to the escalating healthcare expenditure, burgeoning cases of diabetes, and increasing research and development (R&D) activities in the area of biosimilars. According to the National Diabetes Statistics Report 2020 by the Centers for Disease Control and Prevention (CDC), 34.2 million people in the U.S. suffer from diabetes. Out of this, nearly 26.9 million cases are diagnosed, whereas 7.3 million cases remain undiagnosed.

Therefore, the rising cases of diabetes owing to an unhealthy lifestyle will fuel the adoption of HI and delivery devices.

Access Report Summary Human Insulin Market Segmentation Analysis Report